Hassan Kadhim Defines Decentralized Clinical Trials | ProofPilot
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
ProofPilot’s acquisition of Lokavant will have a strong, direct impact on clinical trial...
It’s a familiar story in clinical research: a referral comes through, the patient looks like a...
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...
I am old enough to remember the days before caller ID when poor souls would simply pick up every...
In Part 1 of this series on Reducing Risk in Decentralized Trials, we covered 7 key issues that...
Since 1999, I have been trying to crack the nut of how to scale physician referrals as a successful...
On a recent Diligent Pharma Webinar, Joseph Kim, Chief Strategy Officer of ProofPilot, covered 7...